Fig. 2.
Activation of β2-integrin on monocytes in AMI.
(A) Representative flow cytometric histograms showing β2-integrin activation (mAbs CBRM1/5 and mAb 24) and total Mac-1 expression (mAb Bear1) in one patient with AMI and one with CSA. The broken line represents the nonspecific control mAb. (B) Flow cytometric analysis of healthy controls and patients with CSA or AMI (n = 20 in each group). Values shown are the mean immunofluorescence ± SD.